ASCO
Audio Journal of Oncology in Advance - June 1st, 2007 - reporting from: American Association for Cancer Research Centennial Meeting, April 14-18, Los Angeles
Lawrence Wickerham
Invasive Breast Cancer Chemoprevention Trials Assessed
REFERENCE: ABSTRACT Special Session; American Association for Cancer Research Centennial Meeting, April 14-18, Los Angeles
LAWRENCE WICKERHAM, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh
The best options for preventing invasive breast cancer among women at high risk were assessed at the AACR meeting. Lawrence Wickerham talked about the latest results from chemoprevention trials, which point to a need to rethink the way tamoxifen, raloxifene, and the aromatase inhibitors should be used. In Los Angeles he discussed his conclusions and recommendations with Karen Regester.
LAWRENCE WICKERHAM, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh
The best options for preventing invasive breast cancer among women at high risk were assessed at the AACR meeting. Lawrence Wickerham talked about the latest results from chemoprevention trials, which point to a need to rethink the way tamoxifen, raloxifene, and the aromatase inhibitors should be used. In Los Angeles he discussed his conclusions and recommendations with Karen Regester.
Stanley Gall
Five and a Half Year Results: Bivalent Human Papillomavirus Vaccine Success
REFERENCE: ABSTRACT 4900, American Association for Cancer Research Centennial Meeting, April 14-18, Los Angeles
STANLEY GALL, University of Louisville, Kentucky
Latest data on the bivalent human papillomavirus vaccine for cervical cancer, showing continuing protection, were presented at the American Association for Cancer Research Annual Meeting in Los Angeles. With five and a half years of follow up, Stanley Gall discussed with Karen Regester the success of the vaccine.
STANLEY GALL, University of Louisville, Kentucky
Latest data on the bivalent human papillomavirus vaccine for cervical cancer, showing continuing protection, were presented at the American Association for Cancer Research Annual Meeting in Los Angeles. With five and a half years of follow up, Stanley Gall discussed with Karen Regester the success of the vaccine.
Andrew Lepisto
Theresa Whiteside
Autologous Vaccine: Benefit for Patients With Resectable Pancreatic Cancer?
REFERENCE: ABSTRACT 4896; American Association for Cancer Research Centennial Meeting, April 14-18, Los Angeles
ANDREW LEPISTO, University of Pittsburgh
THERESA WHITESIDE, University of Pittsburgh
An autologous vaccine for pancreatic cancer offers the hope of improving survival, and perhaps even cure, among patients who have resectable tumors. Peter Goodwin talked about the latest findings with Andrew Lepisto, and he asked Theresa Whiteside to give her assessment of the new data.
ANDREW LEPISTO, University of Pittsburgh
THERESA WHITESIDE, University of Pittsburgh
An autologous vaccine for pancreatic cancer offers the hope of improving survival, and perhaps even cure, among patients who have resectable tumors. Peter Goodwin talked about the latest findings with Andrew Lepisto, and he asked Theresa Whiteside to give her assessment of the new data.
To listen this episode please go to ASCO Audio Journal of Oncology in Advance Presentations.
Similar Interviews
Health For All 30 Years After Alma Ata? Mental Health And War»
AliaIbrahim Zai, Egbert Sondorp, Gill Walt, Lucy Gilson, Ravi Narayan, Richard Horton, Vikram Patel, Willem Van De Put
Two important symposia have been held in London to discuss healthcare issues posing significant dilemmas to world leaders in the 21st Century. "The Future of Primary Health Care" was attended by public health experts from around the Globe to assess the best options for improving primary health care in the future. It was held on the 30th anniversary of the Alma Ata Declaration made in 1977 which was intended as a blueprint for health provision and identified primary health care as the means through which the global goal of "Health for All" could be achieved. The second meeting, on "Mental Health in Fragile States", was held to raise the profile of mental health care in zones where conflict has taken place or is still happening. Analyses of the key issues and how to deal with them effectively were discussed by top experts from the London School of Hygiene and Tropical Medicine and associated organisations. Peter Goodwin attended both meetings and talked with some of the key speakers.AliaIbrahim Zai, Egbert Sondorp, Gill Walt, Lucy Gilson, Ravi Narayan, Richard Horton, Vikram Patel, Willem Van De Put
LSHTM Audio News: British Association Special Edition»
Astrid Fletcher, Jo Lines, Sari Kovats, Colin Sutherland, Michel Coleman
Peter Goodwin hears from London School of Hygiene and Tropical Medicine experts speaking at the annual science festival of the British Association for the Advancement of Science held in Liverpool, September 6-10, 2008, and from recent scientific publications on: the health impact of global warming, a tropical virus reaching temperate zones, inequalities in cancer outcomes, how eating oily fish can save your eyesight, and free internet publishing scientific journals.Astrid Fletcher, Jo Lines, Sari Kovats, Colin Sutherland, Michel Coleman
© 2008 Audio Medica - Medical Audio News Interviews & Podcasts. 
Post a comment